Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hye-Soon Kim

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Antioxidants & Redox Signaling|December 23, 2006
Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cellsHye-Jin Kim, Keun-Gyu Park, Eun-Kyung Yoo, et al.
Diabetes|January 30, 2007
Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partnerKeun-Gyu Park, Kyeong-Min Lee, Hye-Young Seo, et al.
Plos One|January 22, 2020
Can a semi-quantitative method replace the current quantitative method for the annual screening of microalbuminuria in patients with diabetes? Diagnostic accuracy and cost-saving analysis considering the potential health burdenYaerim Kim, Seokwoo Park, Myung-Hee Kim, et al.
Gut and Liver|July 9, 2021
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver DiseaseYuna Kim, Eugene Han, Jae Seung Lee, et al.
Atherosclerosis|July 10, 2009
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injuryKyeong-Min Lee, Hyo-Jeong Lee, Mi-Kyung Kim, et al.
Journal of Diabetes Investigation|May 21, 2014
Trend analysis of diabetic prevalence and incidence in a rural area of South Korea between 2003-2008Ji Yun Jeong, Jung-Guk Kim, Bo-Wan Kim, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trialEun-Gyoung Hong, Kyung-Wan Min, SungWan Chun, et al.
Diabetes & Metabolism Journal|June 29, 2013
Safety and efficacy of modern insulin analoguesHye Jin Yoo, Keun Yong Park, Kang Seo Park, et al.
Journal of Diabetes Investigation|May 21, 2014
Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetesJang Won Son, Dong Jun Kim, Chang Beom Lee, et al.
Diabetes & Metabolism Journal|May 4, 2011
Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy studyKun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Antioxidants & Redox Signaling|December 23, 2006
Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cellsHye-Jin Kim, Keun-Gyu Park, Eun-Kyung Yoo, et al.
Diabetes|January 30, 2007
Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partnerKeun-Gyu Park, Kyeong-Min Lee, Hye-Young Seo, et al.
Plos One|January 22, 2020
Can a semi-quantitative method replace the current quantitative method for the annual screening of microalbuminuria in patients with diabetes? Diagnostic accuracy and cost-saving analysis considering the potential health burdenYaerim Kim, Seokwoo Park, Myung-Hee Kim, et al.
Gut and Liver|July 9, 2021
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver DiseaseYuna Kim, Eugene Han, Jae Seung Lee, et al.
Atherosclerosis|July 10, 2009
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injuryKyeong-Min Lee, Hyo-Jeong Lee, Mi-Kyung Kim, et al.
Journal of Diabetes Investigation|May 21, 2014
Trend analysis of diabetic prevalence and incidence in a rural area of South Korea between 2003-2008Ji Yun Jeong, Jung-Guk Kim, Bo-Wan Kim, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trialEun-Gyoung Hong, Kyung-Wan Min, SungWan Chun, et al.
Diabetes & Metabolism Journal|June 29, 2013
Safety and efficacy of modern insulin analoguesHye Jin Yoo, Keun Yong Park, Kang Seo Park, et al.
Journal of Diabetes Investigation|May 21, 2014
Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetesJang Won Son, Dong Jun Kim, Chang Beom Lee, et al.
Diabetes & Metabolism Journal|May 4, 2011
Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy studyKun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, et al.
Pageof 8